Latin America Investor Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Investor Daily.

Press releases published on April 22, 2026

Apr. 22, 2026

Meteora Capital to Attend Uncorrelated Puerto Rico 2026

Indeterminate EIN Presswire

Apr. 22, 2026

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

Indeterminate GlobeNewswire

Apr. 22, 2026

Elevra Lithium Quarterly Activities Report

Indeterminate GlobeNewswire

Apr. 22, 2026

Rogers Communications Announces Voting Results from Annual General Meeting of Shareholders

Indeterminate GlobeNewswire

Apr. 22, 2026

Mirastar Federal Credit Union Launches Community Needs Assessment Survey to Deepen Community Listening and Advance Inclusive Financial Solutions

Indeterminate GlobeNewswire

Apr. 22, 2026

The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire

Apr. 22, 2026

Univest Securities, LLC Ranked 5th in the Q1 2026 U.S. PIPE and Private Placement Markets Investment Banking League Table by Number of Transactions

Indeterminate GlobeNewswire

Apr. 22, 2026

Century Next Financial Corporation Reports 1st Quarter 2026 Results

Indeterminate GlobeNewswire

Apr. 22, 2026

The 2026 NAB Show Wraps with Proof the Future of Media and Entertainment is Expanding Beyond Broadcasting

Indeterminate GlobeNewswire

Apr. 22, 2026

TIGHITCO Enhances Integrated MRO Solutions to Support Aircraft Readiness

Indeterminate EIN Presswire

Apr. 22, 2026

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2026; DECLARES QUARTERLY DIVIDEND OF $0.25 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR THURSDAY, APRIL 23, AT 9:30 AM CENTRAL TIME

Indeterminate GlobeNewswire

Apr. 22, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Indeterminate GlobeNewswire

Apr. 22, 2026

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée

Indeterminate GlobeNewswire

Apr. 22, 2026

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Indeterminate GlobeNewswire

Apr. 22, 2026

TransUnion Applauds FHFA, HUD for Advancing VantageScore in Mortgage Lending

Indeterminate GlobeNewswire

Apr. 22, 2026

Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026

Indeterminate GlobeNewswire

Apr. 22, 2026

AI GPU Rental Launches New AI-Driven Supercomputing to Simplify Bitcoin Passive Earnings

Indeterminate GlobeNewswire

Apr. 22, 2026

Home BancShares, Inc. Announces Second Quarter Dividend

Indeterminate GlobeNewswire

Apr. 22, 2026

Canfor releases 2025 Sustainability Report

Indeterminate GlobeNewswire

Apr. 22, 2026

StorageVault’s Disciplined Operational Execution Delivers Strong Same Store Growth and AFFO Gains in Q1 2026; Increases Dividend

Indeterminate GlobeNewswire